|
|
|
|
|
|
Heat Biologics Inc (HTBX)
|
|
0.59 -0.01 (-1.52%)
|
6/23/2017 4:00pm
|
|
Open:
|
0.60
|
Pre. Close:
|
0.60
|
|
High:
|
0.60
|
Low:
|
0.58
|
|
Volume:
|
168,096
|
Market Cap:
|
21.02M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.61 - 0.68
|
0.68 - 0.79
|
|
Low:
|
0.55 - 0.55
|
0.55 - 0.57
|
|
Close:
|
0.57 - 0.62
|
0.62 - 0.71
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:35:22 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 0.79 One year: 0.88
|
|
Support:
|
Support1: 0.55 Support2: 0.46
|
|
Resistance:
|
Resistance1:
0.67 Resistance2: 0.75
|
|
Pivot:
|
0.64
|
|
Moving Averages:
|
MA(5): 0.60 MA(20): 0.66
MA(100): 0.80 MA(250): 1.04
|
|
MACD:
|
MACD(12,26):
-0.04 Signal(12,26,9): -0.03
|
|
%K %D:
|
%K(14,3): 25.19 %D(3): 25.75
|
|
RSI:
|
RSI(14): 25.93
|
|
52-Week:
|
High: 3.35
Low: 0.55 Change(%): -26.3
|
|
Average Vol(K):
|
3-Month: 275
10-Days 142
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.HTBX has closed above bottom band by 19.0%. Bollinger Bands are 13.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Wed, 26 Apr 2017 10:52:30 GMT
Heat Biologics to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co.
Mon, 26 Jun 2017 07:18:45 GMT
What's Behind the Numbers For Heat Biologics, Inc. (NasdaqCM:HTBX)?
Tue, 21 Mar 2017 13:41:15 GMT
Heat Biologics Reports Positive NSCLC Drug Results (HTBX)
Wed, 30 Nov 2016 22:28:16 GMT
Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the ...
Wed, 16 Nov 2016 12:02:04 GMT
Heat Biologics to Present Topline HS-410 Phase II Bladder Cancer Results at ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
